Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jose Da Silva

Showing results (101-110 of 107) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 107 results.
American Journal of Infection Control|December 27, 2021
Adherence to non-pharmacological preventive measures among healthcare workers in a middle-income country during the first year of the COVID-19 pandemic: Hospital and community settingSilvia Figueiredo Costa, Sebastian Vernal, Pedro Giavina-Bianchi, et al.
Frontiers in Medicine|November 12, 2020
Frequencies of CD33+CD11b+HLA-DR-CD14-CD66b+ and CD33+CD11b+HLA-DR-CD14+CD66b- Cells in Peripheral Blood as Severity Immune Biomarkers in COVID-19Ricardo Wesley Alberca, Milena Mary de Souza Andrade, Anna Cláudia Calvielli Castelo Branco, et al.
JAMA|November 3, 2012
Comparison of allogeneic vs autologous bone marrow–derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trialJoshua M Hare, Joel E Fishman, Gary Gerstenblith, et al.
Circulation Research|January 23, 2014
Does transendocardial injection of mesenchymal stem cells improve myocardial function locally or globally?: An analysis from the Percutaneous Stem Cell Injection Delivery Effects on Neomyogenesis (POSEIDON) randomized trialViky Y Suncion, Eduard Ghersin, Joel E Fishman, et al.
JAMA|November 20, 2013
Transendocardial mesenchymal stem cells and mononuclear bone marrow cells for ischemic cardiomyopathy: the TAC-HFT randomized trialAlan W Heldman, Darcy L DiFede, Joel E Fishman, et al.
Annals of the Rheumatic Diseases|March 8, 2017
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 updateJosef S Smolen, Robert Landewé, Johannes Bijlsma, et al.
Medicine|November 9, 2010
Revisiting human IL-12Rβ1 deficiency: a survey of 141 patients from 30 countriesLudovic de Beaucoudrey, Arina Samarina, Jacinta Bustamante, et al.
Pageof 11

Showing results (101-110 of 107) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 107 results.
American Journal of Infection Control|December 27, 2021
Adherence to non-pharmacological preventive measures among healthcare workers in a middle-income country during the first year of the COVID-19 pandemic: Hospital and community settingSilvia Figueiredo Costa, Sebastian Vernal, Pedro Giavina-Bianchi, et al.
Frontiers in Medicine|November 12, 2020
Frequencies of CD33+CD11b+HLA-DR-CD14-CD66b+ and CD33+CD11b+HLA-DR-CD14+CD66b- Cells in Peripheral Blood as Severity Immune Biomarkers in COVID-19Ricardo Wesley Alberca, Milena Mary de Souza Andrade, Anna Cláudia Calvielli Castelo Branco, et al.
JAMA|November 3, 2012
Comparison of allogeneic vs autologous bone marrow–derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trialJoshua M Hare, Joel E Fishman, Gary Gerstenblith, et al.
Circulation Research|January 23, 2014
Does transendocardial injection of mesenchymal stem cells improve myocardial function locally or globally?: An analysis from the Percutaneous Stem Cell Injection Delivery Effects on Neomyogenesis (POSEIDON) randomized trialViky Y Suncion, Eduard Ghersin, Joel E Fishman, et al.
JAMA|November 20, 2013
Transendocardial mesenchymal stem cells and mononuclear bone marrow cells for ischemic cardiomyopathy: the TAC-HFT randomized trialAlan W Heldman, Darcy L DiFede, Joel E Fishman, et al.
Annals of the Rheumatic Diseases|March 8, 2017
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 updateJosef S Smolen, Robert Landewé, Johannes Bijlsma, et al.
Medicine|November 9, 2010
Revisiting human IL-12Rβ1 deficiency: a survey of 141 patients from 30 countriesLudovic de Beaucoudrey, Arina Samarina, Jacinta Bustamante, et al.
Pageof 11